Comparison of the effect of SFC (Salmeterol Fluticasone Combination) and ICS plus Tulobuterol Patch in asthma : multicenter open-labelled double cross over study

Not Applicable

Recruiting

• Conditions: Asthma

• Registration Number: JPRN-UMIN000002719
• Lead Sponsor: Kansai Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-11-06
• Study Completion: 2010-09-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

1)severe asthma like following examples patients with a past history of asthma attack with airway cannulation or respiratory arrest , CO2 excess symptom, hypoxic convulsion , syncope patients receiving steroid injection or ACTH injection during 4 weeks before registration to this study patients receiving oral steroid or beta2 agonist injection , xanthene injection during 4 weeks before registration to this study 2)patient suspected of infection which has no effective antibacterial drug or deep mycosis 3)uncontrolled diabetes mellitus , hypertension , cardiac disease or hyperthyroidism 4)tuberculosis or respiratory infection 5)patient experienced adverse effect by components of study drug or another inhaled powder medicine 6)patients who is pregnant or suspected of pregnancy , wish to get pregnant , nursing mom 7)patients who don't have ability to agree 8)inappropriate patient for this study from the doctor's viewpoint

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean variation of morning PEF

Secondary Outcome Measures

Name	Time	Method
Pulmonary function (FEV1, V 50,V25) Asthma Control Test Patient questionnaire Mean variation of evening PEF